112 related articles for article (PubMed ID: 3259465)
1. Modulation of a high molecular weight form of transforming growth factor-alpha in human colon carcinoma cell lines.
Watkins LF; Brattain MG; Levine AE
Cancer Lett; 1988 May; 40(1):59-70. PubMed ID: 3259465
[TBL] [Abstract][Full Text] [Related]
2. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J
Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253
[TBL] [Abstract][Full Text] [Related]
3. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
Levine AE; Black B; Brattain MG
J Cell Physiol; 1989 Mar; 138(3):459-66. PubMed ID: 2925796
[TBL] [Abstract][Full Text] [Related]
4. Human colon cancer cell lines secrete alpha TGF-like activity.
Hanauske AR; Buchok J; Scheithauer W; Von Hoff DD
Br J Cancer; 1987 Jan; 55(1):57-9. PubMed ID: 3493023
[No Abstract] [Full Text] [Related]
5. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells.
Marks ME; Ziober BL; Brattain MG
Cancer Res; 1986 Oct; 46(10):5248-58. PubMed ID: 3756877
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.
Hoosein NM; Brattain DE; McKnight MK; Levine AE; Brattain MG
Cancer Res; 1987 Jun; 47(11):2950-4. PubMed ID: 3471320
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
Zipfel PA; Ziober BL; Morris SL; Mulder KM
Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line.
Levine AE; Lewis LR
Cancer Lett; 1993 Jan; 68(1):33-41. PubMed ID: 8422647
[TBL] [Abstract][Full Text] [Related]
9. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta.
Chakrabarty S; Tobon A; Varani J; Brattain MG
Cancer Res; 1988 Jul; 48(14):4059-64. PubMed ID: 3289738
[TBL] [Abstract][Full Text] [Related]
10. Differential role of transforming growth factor-alpha in two human colon-carcinoma cell lines.
Watkins LF; Levine AE
Int J Cancer; 1991 Feb; 47(3):455-60. PubMed ID: 1993555
[TBL] [Abstract][Full Text] [Related]
11. Growth factor production by human colon carcinoma cell lines.
Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R
Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895
[TBL] [Abstract][Full Text] [Related]
12. Production of transforming growth factors by human colon cancer lines.
Coffey RJ; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
[TBL] [Abstract][Full Text] [Related]
13. Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor alpha.
Huang S; Trujillo JM; Chakrabarty S
Int J Cancer; 1992 Dec; 52(6):978-86. PubMed ID: 1459740
[TBL] [Abstract][Full Text] [Related]
14. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.
Mulder KM; Ramey MK; Hoosein NM; Levine AE; Hinshaw XH; Brattain DE; Brattain MG
Cancer Res; 1988 Dec; 48(24 Pt 1):7120-5. PubMed ID: 3191488
[TBL] [Abstract][Full Text] [Related]
15. Involvement of protein kinase C and an elastase-like enzyme in the processing of transforming growth factor-alpha in human colon carcinoma cell lines.
Levine AE
Int J Cancer; 1994 Jul; 58(1):129-34. PubMed ID: 8014008
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line.
Hoosein NM; Brattain DE; McKnight MK; Childress KE; Chakrabarty S; Brattain MG
Cancer Lett; 1988 Jun; 40(2):219-32. PubMed ID: 3164250
[TBL] [Abstract][Full Text] [Related]
17. Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line.
Levine AE; McRae LJ; Hamilton DA; Brattain DE; Yeoman LC; Brattain MG
Cancer Res; 1985 May; 45(5):2248-54. PubMed ID: 3857117
[TBL] [Abstract][Full Text] [Related]
18. Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effects of receptor-blocking antibody.
Karnes WE; Walsh JH; Wu SV; Kim RS; Martin MG; Wong HC; Mendelsohn J; Park JG; Cuttitta F
Gastroenterology; 1992 Feb; 102(2):474-85. PubMed ID: 1732118
[TBL] [Abstract][Full Text] [Related]
19. Loss of epidermal growth factor receptors and release of transforming growth factors do not correlate with sarcoma virus-transformation in clonally-related NIH/3T3-derived cell lines.
Brown KD; Blakeley DM; Roberts P; Avery RJ
Biochem J; 1985 Jul; 229(1):119-25. PubMed ID: 2994627
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET.
Lynch MJ; Pelosi L; Carboni JM; Merwin J; Coleman K; Wang RC; Lin PF; Henry DL; Brattain MG
Cancer Res; 1993 Sep; 53(17):4041-7. PubMed ID: 8358733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
